Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 98-108

  Solomon, Naveenraj L ^a,b   Cheung, Michael C ^a   Byrne, Margaret M ^b   Zhuge, Ying ^a   Franceschi, Dido ^a,b   Livingstone, Alan S ^a,b   Koniaris, Leonidas G ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIA; COMORBIDITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PYLORUS; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH FUNDUS; SURVIVAL TIME; TEACHING HOSPITAL; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REGISTRIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 74649087202     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0679-y     Document Type: Article

References (33)

1. N Khushalani 2008 Cancer of the esophagus and stomach Mayo Clin Proc 83 712 722 10.4065/83.6.712 18533089 (Pubitemid 351810570)
2. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387
3. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727-33.
4. BH Burmeister BM Smithers V Gebski, et al. 2005 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 659 668 10.1016/S1470-2045(05)70288-6 16129366 (Pubitemid 41222756)
5. V Gebski B Burmeister BM Smithers, et al. 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226 234 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D 17329193 (Pubitemid 46291702)
6. DP Kelsen R Ginsberg TF Pajak, et al. 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1979 1984 10.1056/NEJM199812313392704 1:STN:280:DyaK1M%2FnslCjsg%3D%3D 9869669 (Pubitemid 29024130)
7. J Tepper MJ Krasna D Niedzwiecki, et al. 2008 Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 1086 1092 10.1200/JCO.2007.12.9593 1:CAS:528:DC%2BD1cXktVKitr0%3D 18309943
8. SG Urba MB Orringer A Turrisi, et al. 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 313 1:CAS:528:DC%2BD3MXhtVektrs%3D 11208820
9. JD Urschel H Vasan CJ Blewett 2002 A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer Am J Surg 183 274 279 10.1016/S0002-9610(02)00795-X 11943125 (Pubitemid 34273984)
10. TN Walsh N Noonan D Hollywood, et al. 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 467 10.1056/NEJM199608153350702 1:STN:280:DyaK283psF2juw%3D%3D 8672151 (Pubitemid 26269945)
11. JA Ajani K Winter GS Okawara, et al. 2006 Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response J Clin Oncol 24 3953 3958 10.1200/JCO.2006.06.4840 1:CAS:528:DC%2BD28Xps1Sit7w%3D 16921048 (Pubitemid 46630744)
12. D Cunningham WH Allum SP Stenning, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D 16822992
13. KG Janunger L Hafstrom B Glimelius 2002 Chemotherapy in gastric cancer: a review and updated meta-analysis Eur J Surg 168 597 608 10.1080/ 11024150201680005 1:CAS:528:DC%2BD3sXjtlelsrs%3D 12699095 (Pubitemid 36355892)
14. JS Macdonald SR Smalley J Benedetti, et al. 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D 11547741 (Pubitemid 34936653)
15. E Mari I Floriani A Tinazzi, et al. 2000 Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) Ann Oncol 11 837 843 10.1023/A:1008377101672 1:STN:280:DC%2BD3cvks1SgtA%3D%3D 10997811 (Pubitemid 30687895)
16. K Ng JA Meyerhardt CS Fuchs 2007 Adjuvant and neoadjuvant approaches in gastric cancer Cancer J 13 168 174 10.1097/PPO.0b013e318074e351 1:CAS:528:DC%2BD2sXoslGrtbs%3D 17620766
17. I Panzini L Gianni PP Fattori, et al. 2002 Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses Tumori 88 21 27 1:CAS:528:DC%2BD38Xjt1ChtLo%3D 12004845
18. MC Cheung K Hamilton R Sherman, et al. 2009 Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13, 469 surgical patients Ann Surg Oncol 16 3 13 10.1245/s10434-008-0025-9 18600379
19. NJ Petrelli 2008 Not just another article on cancer surgery volume and patient outcomes J Clin Oncol 26 4530 4531 10.1200/JCO.2008.17.4219 18574156
20. N Housri RJ Weil DI Shalowitz LG Koniaris 2008 Should informed consent for cancer treatment include a discussion about hospital outcome disparities? PLoS Med 5 e214 10.1371/journal.pmed.0050214 18942888
21. MM Mooney 2005 Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma J Surg Oncol 92 230 238 10.1002/jso.20364 1:STN:280: DC%2BD2Mnis1WltA%3D%3D 16299790 (Pubitemid 41779304)
22. IG Kaklamanos GR Walker K Ferry, et al. 2003 Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol 10 754 761 10.1245/ASO.2003.03.078 12900366 (Pubitemid 40486875)
23. K Fujitani JA Ajani CH Crane, et al. 2007 Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction Ann Surg Oncol 14 2010 2017 10.1245/s10434-006-9198-2 17342569 (Pubitemid 46988247)
24. NG Coburn A Govindarajan CH Law, et al. 2008 Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients Ann Surg Oncol 15 500 507 10.1245/s10434-007-9640-0 18026800
25. AL Schwer A Ballonoff R McCammon, et al. 2009 Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a Surveillance, Epidemiology, and End-Results Study Int J Radiat Oncol Biol Phys 73 449 455 18538500
26. AG Casson JJ van Lanschot 2005 Improving outcomes after esophagectomy: the impact of operative volume J Surg Oncol 92 262 266 10.1002/jso.20368 16299792 (Pubitemid 41779308)
27. MC Cheung EA Perez MA Molina, et al. 2008 Defining the role of surgery for primary gastrointestinal tract melanoma J Gastrointest Surg 12 731 738 10.1007/s11605-007-0417-3 18058185
28. JC Gutierrez N Kassira RM Salloum, et al. 2007 Surgery for rectal cancer performed at teaching hospitals improves survival and preserves continence J Gastrointest Surg 11 1441 1448 10.1007/s11605-007-0308-7 17876673
29. JC Gutierrez EA Perez FL Moffat, et al. 2007 Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients Ann Surg 245 952 958 10.1097/01.sla.0000250438.04393.a8 17522521 (Pubitemid 46809297)
30. BE Hillner TJ Smith CE Desch 2000 Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care J Clin Oncol 18 2327 2340 1:STN:280:DC%2BD3c3ptFahsg%3D%3D 10829054
31. RA Meguid BS Brooke DC Chang, et al. 2008 Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg 85 1015 1024 10.1016/j.athoracsur.2007.09.046 18291190 (Pubitemid 351253504)
32. TS Riall KA Eschbach CM Townsend Jr, et al. 2007 Trends and disparities in regionalization of pancreatic resection J Gastrointest Surg 11 1242 1251 10.1007/s11605-007-0245-5 17694419
33. MA Molina MC Cheung EA Perez, et al. 2008 African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients Cancer 113 2797 2806 10.1002/cncr.23889 18839393